Innova Captab Limited (INNOVACAP.NS)
INR 905.3
(-0.89%)
INR 905.3
(-0.89%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 943.45 Million INR | 38.84% |
| 2022 | 679.54 Million INR | 6.26% |
| 2021 | 639.53 Million INR | 85.37% |
| 2020 | 345 Million INR | 23.72% |
| 2019 | 278.86 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 294.77 Million INR | 2.63% |
| 2023 Q2 | 229.05 Million INR | 30.19% |
| 2023 Q3 | 251.26 Million INR | 9.7% |
| 2023 Q1 | 175.93 Million INR | -65.11% |
| 2023 FY | 943.45 Million INR | 38.84% |
| 2023 Q4 | 287.21 Million INR | 14.31% |
| 2022 Q3 | 195.79 Million INR | 0.0% |
| 2022 FY | 679.54 Million INR | 6.26% |
| 2022 Q4 | 504.19 Million INR | 157.52% |
| 2021 FY | 639.53 Million INR | 85.37% |
| 2020 FY | 345 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Hikal Limited | 696 Million INR | -35.553% |
| Morepen Laboratories Limited | 961.59 Million INR | 1.887% |
| Albert David Limited | 754.2 Million INR | -25.093% |
| Alembic Limited | 2.68 Billion INR | 64.878% |
| Alkem Laboratories Limited | 17.95 Billion INR | 94.746% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 84.68% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -1183.972% |
| Bajaj HealthCare Limited | -837.93 Million INR | 212.593% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -13203.017% |
| Brooks Laboratories Limited | -195.91 Million INR | 581.551% |
| Eris Lifesciences Limited | 3.91 Billion INR | 75.931% |
| FDC Limited | 3.05 Billion INR | 69.09% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 79.964% |
| Gufic Biosciences Limited | 861.35 Million INR | -9.531% |
| Hester Biosciences Limited | 188.89 Million INR | -399.471% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 77.588% |
| Ind-Swift Limited | 142.31 Million INR | -562.94% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 29.818% |
| Ipca Laboratories Limited | 5.47 Billion INR | 82.763% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -320.002% |
| Jubilant Pharmova Limited | 771 Million INR | -22.367% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -546.137% |
| Laurus Labs Limited | 1.6 Billion INR | 41.236% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | -1.115% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 1139.993% |
| Medico Remedies Limited | 82.9 Million INR | -1037.934% |
| Nectar Lifesciences Limited | 49.95 Million INR | -1788.789% |
| RPG Life Sciences Limited | 876.6 Million INR | -7.626% |
| Sigachi Industries Limited | 571.8 Million INR | -64.996% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 116.628% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.015% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 68.581% |
| Themis Medicare Limited | 435.23 Million INR | -116.766% |
| Unichem Laboratories Limited | -704.74 Million INR | 233.871% |
| Vaishali Pharma Limited | 7.18 Million INR | -13023.522% |
| Venus Remedies Limited | 284.9 Million INR | -231.142% |
| Windlas Biotech Limited | 581.87 Million INR | -62.141% |
| ZIM Laboratories Limited | 172.46 Million INR | -447.042% |
| Orchid Pharma Limited | 921.66 Million INR | -2.364% |
| Procter & Gamble Health Limited | 2 Billion INR | 53.058% |
| Wanbury Limited | 559.56 Million INR | -68.605% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 56.503% |
| Aarti Drugs Limited | 1.71 Billion INR | 44.962% |
| Lupin Limited | 19.14 Billion INR | 95.072% |
| Sakar Healthcare Limited | 116.7 Million INR | -708.378% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 97.027% |
| Divi's Laboratories Limited | 16 Billion INR | 94.103% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 41.586% |
| Mankind Pharma Limited | 19.12 Billion INR | 95.068% |
| Sequent Scientific Limited | -358.69 Million INR | 363.027% |
| Neuland Laboratories Limited | 3 Billion INR | 68.56% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 82.928% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 106.283% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 97.556% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -109.783% |
| Wockhardt Limited | -4.63 Billion INR | 120.377% |
| Bal Pharma Limited | 73.92 Million INR | -1176.278% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 98.306% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -25.036% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -550.61% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 79.36% |
| Shilpa Medicare Limited | 318.74 Million INR | -195.992% |
| Valiant Laboratories Limited | 3.19 Million INR | -29419.712% |
| Ajanta Pharma Limited | 8.16 Billion INR | 88.441% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -1914.34% |
| Granules India Limited | 4.05 Billion INR | 76.723% |
| Medicamen Biotech Limited | 109.31 Million INR | -763.096% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -272.696% |
| Piramal Enterprises Limited | -16.83 Billion INR | 105.604% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 94.304% |
| NATCO Pharma Limited | 13.88 Billion INR | 93.204% |
| Suven Life Sciences Limited | -1.05 Billion INR | 189.787% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 578.219% |
| Strides Pharma Science Limited | -706.14 Million INR | 233.607% |
| Indoco Remedies Limited | 984.6 Million INR | 4.179% |
| Alpa Laboratories Limited | 167.76 Million INR | -462.364% |
| Lasa Supergenerics Limited | -217.3 Million INR | 534.157% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 124.365% |